tiprankstipranks
Avadel Pharmaceuticals (AVDL)
NASDAQ:AVDL
Holding AVDL?
Track your performance easily

Avadel Pharmaceuticals (AVDL) Ownership - Who Owns Avadel Pharmaceuticals?

672 Followers

Avadel Pharmaceuticals (AVDL) Ownership Overview

11.26%11.33%38.65%7.94%30.82%
11.26% Insiders
38.65% Other Institutional Investors
7.94% ETFs
30.82% Public Companies and
Individual Investors
The ownership structure of Avadel Pharmaceuticals (AVDL) stock is a mix of institutional, retail, and individual investors. Approximately 57.92% of the company’s stock is owned by Institutional Investors, 11.26% is owned by Insiders, and 30.82% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Jan 16, 2024
xxxxxxxxxxxxx
$29000

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2024
xxxxxxxxxxxxx
$18029505
Sep 30, 2024
xxxxxxxxxxxxx
$22129109

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,685,350Insider6.33%66,291,181
4,714,732Institution4.89%54,973,775
3,716,242Insider4.10%43,331,382
3,573,550Institution3.71%41,667,593
3,536,379Institution3.67%41,234,179
2,982,600Institution3.10%34,777,116
1,687,313Institution1.75%19,674,070
1,374,724Institution1.43%16,029,282
984,021Institution1.02%11,473,685
470,341Institution0.49%5,484,176

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
4,714,732Institution4.89%54,973,775
2,982,600Institution3.10%34,777,116
984,021Institution1.02%11,473,685
468,323Institution0.49%5,460,646
425,000Institution0.44%4,955,500
280,544Institution0.29%3,271,143
222,661Institution0.23%2,596,227
199,683Institution0.21%2,328,304
157,320Institution0.16%1,834,351
77,165Institution0.08%899,744

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,990,789Institution3.10%46,267,506
2,531,180Institution2.63%29,513,559
834,569Institution0.87%9,731,075
421,055Institution0.44%6,513,721
87,374Institution0.09%1,351,676
51,534Institution0.05%552,444
50,502Institution0.05%541,381
44,432Institution0.05%518,077
36,102Institution0.04%473,478
37,630Institution0.04%438,766

FAQ

Who Owns Avadel Pharmaceuticals (AVDL)?
According to the latest TipRanks data, approximately 38.65% of the company's stock is held by institutional investors, 11.26% is held by insiders, and 30.82% is held by retail investors.
    What percentage of Avadel Pharmaceuticals (AVDL) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 38.65% of Avadel Pharmaceuticals (AVDL) stock is held by institutional investors.
      What percentage of Avadel Pharmaceuticals (AVDL) stock is held by retail investors?
      According to the latest TipRanks data, approximately 30.82% of Avadel Pharmaceuticals (AVDL) stock is held by retail investors.
        Who owns the most shares of Avadel Pharmaceuticals (AVDL)?
        Jeffrey L. Gendell owns the most shares of Avadel Pharmaceuticals (AVDL).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis